Alivus Life Sciences Profit & Loss Annual

BSE: - | NSE: - | ISIN: - | Sector: -

1,051.55 +29.60 (2.90%)Updated : 12 Jun 2026

Interim Data

Annual Data

Fiscal Period	2026	2025	2024	2023
Period End Date	Mar 26	Mar 25	Mar 24	Mar 23
Total Operating Expense	1,855.56	1,763.09	1,661.08	1,560.46
Other Net	60.41	3.28	0.00	0.14
Diluted Weighted Average Shares	12.30	12.29	12.27	12.25
Depreciation/ Amortization	75.36	60.61	53.45	42.09
Operating Income	696.27	623.80	622.14	600.76
Net Income	564.48	485.63	470.89	466.96
Income Availableto Com Excl Extra Ord	564.48	485.63	470.89	466.96
Other Operating Expenses Total	415.51	22.91	29.55	25.57
Net Income Before Taxes	751.31	654.13	631.29	628.61
Net Income After Taxes	564.48	485.63	470.89	466.96
Income Availableto Com Incl Extra Ord	564.48	485.63	470.89	466.96
Costof Revenue Total	1,066.57	1,099.13	1,002.01	1,014.09
Gross Profit	1,485.26	1,287.76	1,281.20	1,147.13
Interest Inc( Exp) Net- Non- Op Total	-5.37	28.88	9.86	28.27
Unusual Expense( Income)	25.66	-	-	-
Diluted Net Income	564.48	485.63	470.89	466.96
DPS- Common Stock Primary Issue	5.00	5.00	22.50	21.00
Provisionfor Income Taxes	186.83	168.50	160.40	161.65
period Type	-	-	-	-
Net Income Before Extra Items	564.48	485.63	470.89	466.96
Total Revenue	2,551.83	2,386.88	2,283.21	2,161.22
period Length	12.00	12.00	12.00	12.00
Revenue	2,551.83	2,386.88	2,283.21	2,161.22
Selling/ General/ Admin Expenses Total	272.47	580.44	576.07	478.71
Diluted Normalized EPS	47.47	39.63	38.43	38.14
Diluted EPS Excluding Extra Ord Items	45.90	39.52	38.38	38.11
Gain( Loss)on Saleof Assets	-	-1.82	-0.70	-0.56

*All figures in crores except per share values

Trending Stocks

919.20+48.90(5.62%)

4,047.15+187.70(4.86%)

391.65+15.85(4.22%)

1,432.00-32.75 (-2.24%)

285.00-1.65 (-0.58%)

Related News